{
  "id": 18635,
  "title": "STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study",
  "url": "https://urgent.news/2026/07/31/stat-novo-nordisk-inflammation-targeting-drug-misses-mark-in-heart",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-31T12:32:46.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/07/31/novo-nordisk-inflammation-heart-disease-ziltivekimab/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent cardiovascular complications.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}